{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:55:20Z","timestamp":1787028920620,"version":"build-2736575974"},"reference-count":114,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"NIEHS R21","doi-asserted-by":"publisher","award":["ES033806"],"award-info":[{"award-number":["ES033806"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Cancer is the second leading cause of mortality worldwide. Despite the available treatment options, a majority of cancer patients develop drug resistance, indicating the need for alternative approaches. Repurposed drugs, such as antiglycolytic and anti-microbial agents, have gained substantial attention as potential alternative strategies against different disease pathophysiologies, including lung cancer. To that end, multiple studies have suggested that the antiglycolytic dichloroacetate (DCA) and the antibiotic salinomycin (SAL) possess promising anticarcinogenic activity, attributed to their abilities to target the key metabolic enzymes, ion transport, and oncogenic signaling pathways involved in regulating cancer cell behavior, including cell survival and proliferation. We used the following searches and selection criteria. (1) Biosis and PubMed were used with the search terms dichloroacetate; salinomycin; dichloroacetate as an anticancer agent; salinomycin as an anticancer agent; dichloroacetate side effects; salinomycin side effects; salinomycin combination therapy; dichloroacetate combination therapy; and dichloroacetate or salinomycin in combination with other agents, including chemotherapy and tyrosine kinase inhibitors. (2) The exclusion criteria included not being related to the mechanisms of DCA and SAL or not focusing on their anticancer properties. (3) All the literature was sourced from peer-reviewed journals within a timeframe of 1989 to 2024. Importantly, experimental studies have demonstrated that both DCA and SAL exert promising anticarcinogenic properties, as well as having synergistic effects in combination with other therapeutic agents, against multiple cancer models. The goal of this review is to highlight the mechanistic workings and efficacy of DCA and SAL as monotherapies, and their combination with other therapeutic agents in various cancer models, with a major emphasis on non-small-cell lung cancer (NSCLC) treatment.<\/jats:p>","DOI":"10.3390\/medsci13020047","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:38:37Z","timestamp":1745390317000},"page":"47","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dichloroacetate and Salinomycin as Therapeutic Agents in Cancer"],"prefix":"10.3390","volume":"13","author":[{"given":"Sunny","family":"Hunt","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, Oberlin College, 173 W Lorain St, Oberlin, OH 44074, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Thyagarajan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Dayton, OH 45435, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3857-9073","authenticated-orcid":false,"given":"Ravi P.","family":"Sahu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Dayton, OH 45435, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer Statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer Progress and Priorities: Lung Cancer","volume":"28","author":"Schabath","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung Cancer 2020: Epidemiology, Etiology, and Prevention","volume":"41","author":"Bade","year":"2020","journal-title":"Clin. Chest Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0033-8389(05)70176-7","article-title":"Epidemiology of lung cancer","volume":"38","author":"Smith","year":"2000","journal-title":"Radiol. Clin. N. Am."},{"key":"ref_6","unstructured":"(2025, April 01). Lung Cancer Statistics|How Common is Lung Cancer? (n.d.). American Cancer Society. Available online: https:\/\/www.cancer.org\/cancer\/types\/lung-cancer\/about\/key-statistics.html."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1188\/08.CJON.587-596","article-title":"Updates in non-small cell lung cancer","volume":"12","author":"Walker","year":"2008","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/1759-7714.12869","article-title":"Location of stage I-III non-small cell lung cancer and survival rate: Systematic review and meta-analysis","volume":"9","author":"Lee","year":"2018","journal-title":"Thorac. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Li, Y., Yan, B., and He, S. (2023). Advances and challenges in the treatment of lung cancer. Biomed. Pharmacother., 169.","DOI":"10.1016\/j.biopha.2023.115891"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wu, J., and Lin, Z. (2022). Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315056"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.32471\/exp-oncology.2312-8852.vol-44-no-1.17411","article-title":"Current therapeutic strategies and challenges in nsclc treatment: A comprehensive review","volume":"44","author":"Kumar","year":"2022","journal-title":"Exp. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105583","DOI":"10.1016\/j.phrs.2021.105583","article-title":"EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research","volume":"167","author":"Dong","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jtho.2016.12.014","article-title":"Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR-Mutated Non-Small Cell Lung Cancer","volume":"12","author":"Castellanos","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7888\/juoeh.41.153","article-title":"Treatment of Non-small Cell Lung Cancer with EGFR-mutations","volume":"41","author":"Yoneda","year":"2019","journal-title":"J. UOEH"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.hoc.2012.02.001","article-title":"Tyrosine kinase inhibitors in lung cancer","volume":"26","author":"Thomas","year":"2012","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12943-018-0801-5","article-title":"Advances in studies of tyrosine kinase inhibitors and their acquired resistance","volume":"17","author":"Jiao","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.pharmtox.45.120403.100124","article-title":"Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics","volume":"45","author":"Tibes","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kang, H., Kim, B., Park, J., Youn, H., and Youn, B. (2023). The Warburg effect on radioresistance: Survival beyond growth. Biochim. Biophys. Acta Rev. Cancer, 1878.","DOI":"10.1016\/j.bbcan.2023.188988"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","article-title":"The Warburg effect: Essential part of metabolic reprogramming and central contributor to cancer progression","volume":"95","author":"Vaupel","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1871520616666161031143301","article-title":"The Warburg Effect and the Hallmarks of Cancer","volume":"17","author":"Schwartz","year":"2017","journal-title":"Anticancer. Agents Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","article-title":"How the Warburg effect supports aggressiveness and drug resistance of cancer cells?","volume":"38","author":"Icard","year":"2018","journal-title":"Drug Resist. Updat."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does it Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_24","first-page":"617","article-title":"Dichloroacetate and cancer: New home for an orphan drug?","volume":"1846","author":"Kankotia","year":"2014","journal-title":"Biochem. Biophys. Acta"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Koltai, T., and Fliegel, L. (2024). Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts. Pharmaceuticals, 17.","DOI":"10.20944\/preprints202403.0254.v1"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3892\/mmr_00000296","article-title":"Salinomycin in cancer: A new mission for an old agent","volume":"3","author":"Naujokat","year":"2010","journal-title":"Mol. Med. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Naujokat, C., and Steinhart, R. (2012). Salinomycin as a drug for targeting human cancer stem cells. J. Biomed. Biotechnol., 2012.","DOI":"10.1155\/2012\/950658"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.2174\/15672050113109990199","article-title":"Salinomycin: A novel anti-cancer agent with known anti-coccidial activities","volume":"20","author":"Zhou","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Wang, H., Zhang, H., Zhu, Y., Wu, Z., Cui, C., and Cai, F. (2021). Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.654428"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1747-0285.2011.01287.x","article-title":"Salinomycin: A new cancer drug candidate","volume":"79","author":"Huczynski","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/diacare.15.6.785","article-title":"Dichloroacetate","volume":"15","author":"Stacpoole","year":"1992","journal-title":"Diabetes Care"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0026-0495(89)90051-6","article-title":"The pharmacology of dichloroacetate","volume":"38","author":"Stacpoole","year":"1989","journal-title":"Metabolism"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8201079","DOI":"10.1155\/2019\/8201079","article-title":"Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications","volume":"2019","author":"Tataranni","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3176375","DOI":"10.1155\/2020\/3176375","article-title":"Antitumor Therapy under Hypoxic Microenvironment by the Combination of 2-Methoxyestradiol and Sodium Dichloroacetate on Human Non-Small-Cell Lung Cancer","volume":"2020","author":"Romero","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","article-title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer","volume":"99","author":"Michelakis","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/onc.2012.198","article-title":"Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer","volume":"32","author":"Sutendra","year":"2013","journal-title":"Oncogene"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Dyrstad, S.E., Lotsberg, M.L., Tan, T.Z., Pettersen, I.K.N., Hjellbrekke, S., Tusubira, D., Engelsen, A.S.T., Daubon, T., Mourier, A., and Thiery, J.P. (2021). Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells. Cancers, 13.","DOI":"10.3390\/cancers13050941"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"\u0160korja Mili\u0107, N., Dolinar, K., Mi\u0161, K., Matkovi\u010d, U., Bizjak, M., Pavlin, M., Podbregar, M., and Pirkmajer, S. (2021). Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1\u03b1. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168610"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"104511","DOI":"10.1016\/j.phrs.2019.104511","article-title":"Targeting glucose metabolism to suppress cancer progression: Prospective of anti-glycolytic cancer therapy","volume":"150","author":"Mahmoud","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10549-009-0435-9","article-title":"Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo","volume":"120","author":"Sun","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13402-014-0212-6","article-title":"Mitochondrial induction as a potential radio-sensitizer in lung cancer cells\u2014A short report","volume":"38","author":"Shavit","year":"2015","journal-title":"Cell. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.freeradbiomed.2015.08.006","article-title":"Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cells","volume":"89","author":"Allen","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5487\/TR.2016.32.3.177","article-title":"Targeting Cancer Metabolism\u2014Revisiting the Warburg Effects","volume":"32","author":"Tran","year":"2016","journal-title":"Toxicol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40880-017-0219-2","article-title":"Autophagy and multidrug resistance in cancer","volume":"36","author":"Li","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1615\/CritRevOncog.2020034969","article-title":"Autophagy-Induced Drug Resistance in Liver Cancer","volume":"25","author":"Vempati","year":"2020","journal-title":"Crit. Rev. Oncog."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","article-title":"Biological Functions of Autophagy Genes: A Disease Perspective","volume":"176","author":"Levine","year":"2019","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/bjc.2014.281","article-title":"Dichloroacetate induces autophagy in colorectal cancer cells and tumours","volume":"111","author":"Lin","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2147\/CMAR.S156530","article-title":"Dichloroacetate enhances the antitumor efficacy of chemotherapeutic agents via inhibiting autophagy in non-small-cell lung cancer","volume":"10","author":"Lu","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1289\/ehp.1002554","article-title":"The dichloroacetate dilemma: Environmental hazard versus therapeutic goldmine--both or neither?","volume":"119","author":"Stacpoole","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/bs.irn.2019.05.003","article-title":"Dichloroacetate-induced peripheral neuropathy","volume":"145","author":"Stacpoole","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-981-32-9636-7_23","article-title":"Drug-Induced Demyelinating Neuropathies","volume":"1190","author":"Niimi","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"52642","DOI":"10.18632\/oncotarget.16991","article-title":"Suppression of pyruvate dehydrogenase kinase-2 re-sensitizes paclitaxel-resistant human lung cancer cells to paclitaxel","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"ref_53","first-page":"409","article-title":"Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells","volume":"38","author":"Xie","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00432-014-1583-9","article-title":"Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer","volume":"140","author":"Garon","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Al-Azawi, A., Sulaiman, S., Arafat, K., Yasin, J., Nemmar, A., and Attoub, S. (2021). Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212553"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Schoenmann, N., Tannenbaum, N., Hodgeman, R.M., and Raju, R.P. (2023). Regulating mitochondrial metabolism by targeting pyruvate dehydrogenase with dichloroacetate, a metabolic messenger. Biochim. Biophys. Acta Mol. Basis Dis., 1869.","DOI":"10.1016\/j.bbadis.2023.166769"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e00537-21","DOI":"10.1128\/mBio.00537-21","article-title":"Anaerobic Microbial Metabolism of Dichloroacetate","volume":"12","author":"Chen","year":"2021","journal-title":"Mbio"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejphar.2016.08.004","article-title":"Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines","volume":"789","author":"Yang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbrc.2017.05.097","article-title":"Sensitization of breast cancer cells to paclitaxel by dichloroacetate through inhibiting autophagy","volume":"489","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00280-013-2281-z","article-title":"DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft","volume":"72","author":"Zheng","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"De Mey, S., Dufait, I., Jiang, H., Corbet, C., Wang, H., Van De Gucht, M., Kerkhove, L., Law, K.L., Vandenplas, H., and Gevaert, T. (2020). Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249367"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Cook, K.M., Shen, H., McKelvey, K.J., Gee, H.E., and Hau, E. (2021). Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147265"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"59458","DOI":"10.18632\/oncotarget.10694","article-title":"Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10549-014-3128-y","article-title":"Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells","volume":"147","author":"Haugrud","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Parczyk, J., Ruhnau, J., Pelz, C., Schilling, M., Wu, H., Piaskowski, N.N., Eickholt, B., K\u00fchn, H., Danker, K., and Klein, A. (2021). Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08186-9"},{"key":"ref_66","first-page":"e21884","article-title":"Synergistic Anti-Tumor Effect of Dichloroacetate and Ivermectin","volume":"14","author":"Ishiguro","year":"2022","journal-title":"Cureus"},{"key":"ref_67","unstructured":"(2025, April 01). Salinomycin. Nih.gov; PubChem, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Salinomycin."},{"key":"ref_68","unstructured":"(2025, April 01). SALINOMYCIN MYCELIA-Salinomycin Powder. DailyMed 2020. Nih.gov, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=76ecb04c-f8c3-4607-9681-1909a3ffb22e."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.2460\/javma.230.12.1822","article-title":"Salinomycin toxicosis in horses","volume":"230","author":"Aleman","year":"2007","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_70","first-page":"305","article-title":"Effect of salinomycin-Na on malaria parasites (Plasmodium falciparum and P. berghei)","volume":"256","author":"Mehlhorn","year":"1984","journal-title":"Zentralbl Bakteriol. Mikrobiol. Hyg. A"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bj.2020.05.003","article-title":"Repurposing old drugs as antiviral agents for coronaviruses","volume":"43","author":"Yang","year":"2020","journal-title":"Biomed. J."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Yuan, C., Huang, X., Zhai, R., Ma, Y., Xu, A., Zhang, P., and Yang, Q. (2021). In Vitro Antiviral Activities of Salinomycin on Porcine Epidemic Diarrhea Virus. Viruses, 13.","DOI":"10.3390\/v13040580"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.bmcl.2012.05.081","article-title":"Synthesis and antimicrobial activity of amide derivatives of polyether antibiotic-salinomycin","volume":"22","author":"Janczak","year":"2012","journal-title":"Bioorg Med. Chem. Lett."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.14202\/vetworld.2022.2244-2252","article-title":"Hepatoprotective and renoprotective effects of silymarin against salinomycin-induced toxicity in adult rabbits","volume":"15","author":"Ghonaim","year":"2022","journal-title":"Vet. World"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/bjc.2011.530","article-title":"Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress","volume":"106","author":"Ketola","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2020.02.015","article-title":"Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs","volume":"483","author":"Su","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nchem.2778","article-title":"Salinomycin kills cancer stem cells by sequestering iron in lysosomes","volume":"9","author":"Mai","year":"2017","journal-title":"Nat. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/1871520615666150101130209","article-title":"Anticancer Activity of Polyether Ionophore-Salinomycin","volume":"15","author":"Antoszczak","year":"2015","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","article-title":"Cancer Stem Cells: Basic Concepts and Therapeutic Implications","volume":"11","author":"Nassar","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12032-021-01488-9","article-title":"Cancer stem cells in colorectal cancer and the association with chemotherapy resistance","volume":"38","author":"Lei","year":"2021","journal-title":"Med. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1615\/CritRevOncog.2019029512","article-title":"Cancer Stem Cells: Root of the Evil","volume":"24","author":"Erkisa","year":"2019","journal-title":"Crit. Rev. Oncog."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Makena, M.R., Ranjan, A., Thirumala, V., and Reddy, A.P. (2020). Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance. Biochim. Biophys. Acta Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2018.11.015"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Dewangan, J., Srivastava, S., and Rath, S.K. (2017). Salinomycin: A new paradigm in cancer therapy. Tumour Biol., 39.","DOI":"10.1177\/1010428317695035"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/med.21870","article-title":"Salinomycin as a potent anticancer stem cell agent: State of the art and future directions","volume":"42","author":"Qi","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.18632\/oncotarget.2657","article-title":"Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4\/ALK and LKB1 status","volume":"5","author":"Xiao","year":"2014","journal-title":"Oncotarget"},{"key":"ref_87","first-page":"2045","article-title":"Cancer stem cell targets\u2014A review","volume":"20","author":"Zhang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Tefas, L.R., Barb\u0103lat\u0103, C., Tefas, C., and Tomu\u021b\u0103, I. (2021). Salinomycin-Based Drug Delivery Systems: Overcoming the Hurdles in Cancer Therapy. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13081120"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2019.01.034","article-title":"A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents","volume":"166","author":"Antoszczak","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_90","first-page":"2399","article-title":"Wnt blockers inhibit the proliferation of lung cancer stem cells","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des. Devel Ther."},{"key":"ref_91","first-page":"630","article-title":"Salinomycin Suppresses Tumorigenicity of Liver Cancer Stem Cells and Wnt\/Beta-catenin Signaling","volume":"16","author":"Liu","year":"2021","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.3892\/ol.2016.4323","article-title":"The impact of metformin and salinomycin on transforming growth factor \u03b2-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell lines","volume":"11","author":"Koeck","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7150\/ijms.50080","article-title":"Salinomycin suppresses TGF-\u03b21-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK\/SIRT1 pathway in non-small cell lung cancer","volume":"18","author":"Hwang","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Arafat, K., Iratni, R., Takahashi, T., Parekh, K., Al Dhaheri, Y., Adrian, T.E., and Attoub, S. (2013). Inhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066931"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbrc.2011.08.054","article-title":"Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization","volume":"413","author":"Kim","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4161\/auto.24632","article-title":"Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells","volume":"9","author":"Li","year":"2013","journal-title":"Autophagy"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.bbamcr.2013.04.011","article-title":"Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: Differences between primary and cancer cells","volume":"1833","author":"Jangamreddy","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbamcr.2014.12.022","article-title":"Monitoring of autophagy is complicated--salinomycin as an example","volume":"1853","author":"Jangamreddy","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbrc.2009.10.042","article-title":"Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells","volume":"390","author":"Fuchs","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00109-014-1155-0","article-title":"Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice","volume":"92","author":"Boehmerle","year":"2014","journal-title":"J. Mol. Med."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Ojo, O.O., Bhadauria, S., and Rath, S.K. (2019). Correction: Dose-dependent adverse effects of salinomycin on male reproductive organs and fertility in mice. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0226872"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yexcr.2017.04.026","article-title":"Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells","volume":"357","author":"Tung","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bcp.2016.09.022","article-title":"Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression","volume":"122","author":"Ko","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/bs.podrm.2019.10.004","article-title":"Erlotinib","volume":"45","author":"Abdelgalil","year":"2020","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gpb.2014.10.003","article-title":"Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer","volume":"12","author":"Rose","year":"2014","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Michalak, M., Lach, M.S., Antoszczak, M., Huczy\u0144ski, A., and Suchorska, W.M. (2020). Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives-An In Vitro Study. Molecules, 25.","DOI":"10.3390\/molecules25030537"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"22414","DOI":"10.18632\/oncotarget.5628","article-title":"Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer","volume":"8","author":"Zou","year":"2017","journal-title":"Oncotarget"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Skeberdyt\u0117, A., Sarapinien\u0117, I., Aleksander-Krasko, J., Stankevi\u010dius, V., Su\u017eied\u0117lis, K., and Jarmalait\u0117, S. (2018). Dichloroacetate and Salinomycin Exert a Synergistic Cytotoxic Effect in Colorectal Cancer Cell Lines. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-35815-4"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.bbrc.2019.12.107","article-title":"Salinomycin and dichloroacetate synergistically inhibit Lewis lung carcinoma cell proliferation, tumor growth and metastasis","volume":"523","author":"Krasko","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Wei, M., Shen, X., Liu, Y., Chen, X., Su, S., Lv, X., Qian, X., Yu, L., and Wang, L. (2024). The antitumor effect of diisopropylamine dichloroacetate on non-small cell lung cancer and its influence on the tumor immune microenvironment. Front. Oncol., 29.","DOI":"10.3389\/fonc.2024.1447828"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"102644","DOI":"10.1016\/j.nantod.2025.102644","article-title":"Modulating autophagy in the tumor microenvironment with a salinomycin-loaded liposome hybrid nanovesicle system for tumor immunotherapy","volume":"61","author":"Li","year":"2025","journal-title":"Nanotoday"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Vaghari-Tabari, M., Hassanpour, P., Sadeghsoltani, F., Malakoti, F., Alemi, F., Qujeq, D., Asemi, Z., and Yousefi, B. (2022). CRISPR\/Cas9 gene editing: A new approach for overcoming drug resistance in cancer. Cell Mol. Biol. Lett., 27.","DOI":"10.1186\/s11658-022-00348-2"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e694","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: A brief overview","volume":"12","author":"Jovic","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-1-0716-1307-8_19","article-title":"Single-Cell RNA Sequencing Analysis: A Step-by-Step Overview","volume":"2284","author":"Slovin","year":"2021","journal-title":"Methods Mol. Biol."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/2\/47\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:19:54Z","timestamp":1760030394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/2\/47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":114,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["medsci13020047"],"URL":"https:\/\/doi.org\/10.3390\/medsci13020047","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]}}}